Elsevier

World Neurosurgery

Volume 88, April 2016, Pages 592-597
World Neurosurgery

Original Article
Mortality in Elderly Patients Operated for an Acute Subdural Hematoma: A Surgical Case Series

https://doi.org/10.1016/j.wneu.2015.10.095Get rights and content

Background

Surgery for elderly patients with acute subdural hematomas (ASDH) is controversial, because postoperative mortality rates are reported to be high and long-term outcomes unknown. Thus, we aimed to describe midterm and long-term mortality rates of elderly patients operated for an ASDH.

Methods

We reviewed all consecutive ≥75-year-old patients operated on for an ASDH between 2009 and 2012. We recorded data on preadmission functional status (independent or dependent) and use of antithrombotic medication. Patients were followed up a median of 4.2 years (range, 2.5–6.4 years).

Results

Forty-four patients were included. The majority of the patients (70%) were independent and taking antithrombotic medication (77%). Independent patients had a 1-year mortality of 42%, compared to 69% for dependent patients; 56% of patients taking antithrombotics and 30% of those without antithrombotics died within the first postoperative year. All patients with an admission Glasgow coma scale score of 3–8 died within the first postoperative year, if they used antithrombotics or were dependent before the injury. Of all 1-year survivors, 77% were alive at the end of follow-up.

Conclusion

In this first surgical case series of 75-year-old or older patients with ASDH, the overall mortality rate appears to be relatively low, especially for preoperatively conscious and independent patients without antithrombotic medication. Patients alive at 1-year after surgery had a life expectancy comparable to their age-matched peers. The prognosis seems to be detrimental for preoperatively unconscious patients who were functionally dependent or used antithrombotic medication before the injury.

Introduction

The mean age of patients with traumatic brain injury (TBI) is rapidly increasing, especially in the Western world.1, 2 During the last decades, the median age of patients with TBI has increased from 25 to 55 years, and it presumably continues to increase in the future.3, 4, 5, 6, 7, 8 Current treatment guidelines are based on studies performed on much younger study populations than commonly seen in daily practice.9 In elderly patients with TBI, particularly, the use of antithrombotic medication together with comorbidities poses treatment challenges.

Early studies from the era preceding computed tomography have shown poor outcome for patients with acute subdural hematomas (ASDHs),10 and even poorer outcome in the elderly.11 Nowadays, craniotomy and hematoma evacuation is standard care for patients with expansive ASDHs.9 For younger patients (<65 years old), large observational cohorts have reported mortality rates of 35%–55%, despite the surgical evacuation of hematoma. For patients older than 65 years, studies from the 1980s and 1990s have reported much higher postoperative mortality rates, ranging from 74% to 88%.12, 13, 14, 15, 16, 17, 18 Since the turn of the millennium, only a few studies have reported outcomes of elderly patients with surgically treated ASDHs, and reported mortality rates have varied between 35% and 50%.19, 20, 21 However, no studies focusing on patients of 75 years of age and older have been published.

In the current study, we analyzed medium-term and long-term (1- and 3-year) mortality rates of elderly patients (≥75 years old) operated on for ASDHs in our institution between 2009 and 2012. We specifically aimed to determine the role of pretrauma functional status and usage of antithrombotic medications on mortality rates, and estimate excess mortality rates for elderly ASDH survivors.

Section snippets

Study Population and Data Collection

We conducted a retrospective case series study including all elderly patients (defined as age ≥ 75 years) operated consecutively for ASDHs in our level 1 trauma center (Helsinki University Hospital) between January 1, 2009, and December 31, 2012. Our trauma center is a public, nonprofit hospital with a catchment area of nearly 2 million people, being the largest trauma center in Finland.

We included only TBI patients whose main finding was an ASDH, and who were operated on an emergency basis

Baseline Characteristics

During the study period between 2009 and 2012, 1000 patients with TBIs were treated in our neurosurgical intensive care unit. Of these, 124 patients were 75 years of age or older. Of the 124 patients, 76 patients had an operable ASDH without any other major intracranial injuries. Of these, 44 patients were operated on and included in the present study. Of the included 44 patients, 70% (n = 31/44) were independent and 30% (n = 13/44) were dependent before injury. Only 4 patients (9%) lived in a

Discussion

In this first study of medium-term and long-term mortality rates after emergency surgery for ASDHs in 75-year-old and older patients, 22 of 44 operated elderly patients were alive at 1 year. Only 5 of 22 one-year survivors died during the following 2 years. Of the 17 three-year survivors, no one died during the follow-up. Thus, 1-year survivors seem to have a mortality rate comparable to their peers. As for younger patients with TBI, the level of consciousness on admission, measured using the

Conclusion

In this first surgical case series of 75-year-old or older patients with ASDH, the overall mortality rate appears to be relatively low, especially for preoperatively conscious and independent patients without antithrombotic medication. The prognosis seems to be detrimental for preoperatively unconscious patients being dependent or taking antithrombotic medication. Patients who were alive 1 year after surgery had a life expectancy comparable to their age-matched peers.

References (27)

  • N. Stocchetti et al.

    Traumatic brain injury in an aging population

    J Neurotrauma

    (2012)
  • Brain Trauma Foundation

    American Association of Neurological Surgeons, Congress of Neurological Surgeons: Guidelines for the management of severe traumatic brain injury

    J Neurotrauma

    (2007)
  • J. Hernesniemi

    Outcome following acute subdural haematoma

    Acta Neurochir (Wien)

    (1979)
  • Cited by (41)

    • Embolization of the Middle meningeal artery in chronic subdural hematoma — A systematic review

      2019, Clinical Neurology and Neurosurgery
      Citation Excerpt :

      Moreover, the complication rate related directly to the MMAE was of 3.6%. Given that the one-year mortality rate of cSDH reported in other studies is up to 69% in dependent patients [46] and that diagnostic angiography procedures have a well-documented complication rate of 0–2.6%, the accuracy of the safety assessment performed in the reviewed studies is doubtful [47,48]. The low rates of morbidity/mortality could be due to the short length of available follow-up, which totaled a median of 6 months, poor documentation of complications in the charts or due to selection bias.

    • Short- and Long-Term Geriatric Mortality After Acute Traumatic Subdural Hemorrhage

      2019, World Neurosurgery
      Citation Excerpt :

      Considering this, the use of antithrombotic medications in this age group has been steadily increasing despite the inherent risk of hemorrhagic complications and high fall risks.15 Premorbid antithrombotic use has been described as both an important15,22,36 and unimportant3,12,17,23,24,44 contributor to mortality after acute SDH in the geriatric population; however, our results clearly indicate a significant decrease in late survival for these patients. How much these observations can be attributed to the poor level of health intrinsic to those patients on these medications before presentation is still a matter of debate, but it follows that they are likely more debilitated at baseline with less reserve and a greater propensity for larger acute SDH volumes.

    View all citing articles on Scopus

    Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

    The study was funded by grants from Finska Läkaresällskapet, Medicinska Understödsföreningen Liv och Hälsa, and the Maud Kuistila Memorial foundation.

    View full text